Abstract
The effect of six weeks' treatment with inhaled terbutaline (1 mg four times a day), optimised doses of theophylline (twice a day), the combination of theophylline and terbutaline, and placebo was studied in a randomised, double blind, crossover trial. Thirty patients with partially reversible chronic airflow obstruction and a mean forced expiratory volume in one second (FEV1) of 1.2 litres that improved by 25% were included in the study. Patients who developed non-infective exacerbations of airflow obstruction that required additional bronchodilator treatment were classed as "treatment failures." Such treatment failure occurred in 23 patients with placebo, in 22 patients with theophylline, in 12 patients with terbutaline, and in two patients taking the two drugs. Mean daily peak flow readings were highest with the combination of the two drugs, followed by terbutaline and then theophylline, and lowest with placebo. Thus a combination of terbutaline and theophylline was superior to either drug alone; inhaled terbutaline was superior to theophylline alone. Theophylline alone does not appear to have much place in the management of patients with partially reversible obstructive airways disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson G., Peel E. T., Pardoe T., Jones R. Sustained-release theophylline in chronic bronchitis. Br J Dis Chest. 1982 Jul;76(3):261–265. [PubMed] [Google Scholar]
- Anderson G., Peel E. T., Pardoe T., Jones R. Sustained-release theophylline in chronic bronchitis. Br J Dis Chest. 1982 Jul;76(3):261–265. [PubMed] [Google Scholar]
- Au W. Y., Dutt A. K., DeSoyza N. Theophylline kinetics in chronic obstructive airway disease in the elderly. Clin Pharmacol Ther. 1985 Apr;37(4):472–478. doi: 10.1038/clpt.1985.74. [DOI] [PubMed] [Google Scholar]
- Corris P. A., Neville E., Nariman S., Gibson G. J. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction. Thorax. 1983 Apr;38(4):292–296. doi: 10.1136/thx.38.4.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dull W. L., Alexander M. R. Theophylline in stable chronic airflow obstruction. A reappraisal. Arch Intern Med. 1984 Dec;144(12):2399–2401. [PubMed] [Google Scholar]
- Dullinger D., Kronenberg R., Niewoehner D. E. Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction. Chest. 1986 Feb;89(2):171–173. doi: 10.1378/chest.89.2.171. [DOI] [PubMed] [Google Scholar]
- Guyatt G. H., Townsend M., Pugsley S. O., Keller J. L., Short H. D., Taylor D. W., Newhouse M. T. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis. 1987 May;135(5):1069–1074. doi: 10.1164/arrd.1987.135.5.1069. [DOI] [PubMed] [Google Scholar]
- Rogers R. M., Owens G. R., Pennock B. E. The pendulum swings again. Toward a rational use of theophylline. Chest. 1985 Mar;87(3):280–282. doi: 10.1378/chest.87.3.280. [DOI] [PubMed] [Google Scholar]
- Shenfield G. M. Combination bronchodilator therapy. Drugs. 1982 Nov;24(5):414–439. doi: 10.2165/00003495-198224050-00004. [DOI] [PubMed] [Google Scholar]
- Smith J. A., Weber R. W., Nelson H. S. Theophylline and aerosolized terbutaline in the treatment of bronchial asthma. Double-blind comparison of optimal doses. Chest. 1980 Dec;78(6):816–818. doi: 10.1378/chest.78.6.816. [DOI] [PubMed] [Google Scholar]
- Taylor D. R., Buick B., Kinney C., Lowry R. C., McDevitt D. G. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Am Rev Respir Dis. 1985 May;131(5):747–751. doi: 10.1164/arrd.1985.131.5.747. [DOI] [PubMed] [Google Scholar]